Jianqin Lu, BPharm, PhD

Jianqin Lu headshot

Biography

Dr. Lu obtained his Ph.D. at the University of Pittsburgh in 2014 and then performed postdoctoral training on nanomedicine and tumor immunology at the University of Chicago and UCLA. He joined the University of Arizona as an Assistant Professor of Pharmaceutical Sciences in 2019 and was promoted to Associate Professor with tenure in 2024. His research has been supported by the NIH/NIGMS Maximizing Investigators' Research Award (MIRA) (R35), the NIH/NCI R01, Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Faculty Starter Grant in Drug Delivery, UArizona Comprehensive Cancer Center, and the State of Arizona's Technology and Research Initiative Fund (TRIF)/BIO5 Institute as well as The Southwest Environmental Health Sciences Center (SWEHSC). Dr. Lu serves as the Director of the Pharmaceutics and Pharmacokinetics Track at the R. Ken Coit College of Pharmacy. He is a chartered member in NIH Drug and Biologic Therapeutic Delivery (DBTD) study section and serves on the editorial board in Journal of Drug Targeting. 

Cancer Focus

Dr. Lu’s lab strives to develop innovative, safe, and efficacious nanotherapeutics at the interface of drug delivery, synthetic chemistry, molecular pharmaceutics, nanoengineering, and tumor immunology to address the pressing unmet needs in colorectal cancer, pancreatic cancer, breast cancer, melanoma, and lymphoma.
 
Research Program Role
Clinical and Translational Oncology Program

Display Name
Jianqin Lu, BPharm, PhD